Celestone and Soma drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celestone (betamethasone) and Soma (carisoprodol). Common drug interactions include road traffic accident among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Celestone and Soma. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Celestone?

Celestone has active ingredients of betamethasone. It is often used in bursitis. eHealthMe is studying from 1,788 Celestone users. Check the latest studies of Celestone.

What is Soma?

Soma has active ingredients of carisoprodol. It is often used in muscle spasms. eHealthMe is studying from 17,137 Soma users. Check the latest studies of Soma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

25 people who take Celestone and Soma together, and have interactions are studied.

Celestone and Soma drug interactions.

What are the common drug interactions of Celestone and Soma, by gender? *:

female:

  1. Road traffic accident
  2. Upper respiratory tract infection
  3. Weight increased
  4. Drug ineffective
  5. Vomiting
  6. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Fall
  9. Nausea (feeling of having an urge to vomit)
  10. Neuropathy peripheral (surface nerve damage)

male:

  1. Constipation
  2. Depression
  3. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  4. Confusional state
  5. Emotional distress
  6. Hepatomegaly (abnormal enlargement of the liver)
  7. Loss of consciousness
  8. Overdose
  9. Splenomegaly (enlargement of spleen)
  10. Urinary retention (the inability to completely or partially empty the bladder)

What are the common drug interactions of Celestone and Soma, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Constipation
  2. Depression
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Insomnia (sleeplessness)
  5. Drug abuser
  6. Drug dependence
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  9. Confusional state
  10. Dyspnoea (difficult or laboured respiration)

40-49:

n/a

50-59:

  1. Pneumonia bacterial (pneumonia associated with bacterial infection)
  2. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  3. Road traffic accident
  4. Upper respiratory tract infection
  5. Weight increased
  6. Drug ineffective
  7. Vomiting
  8. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Fall

60+:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Alcohol abuse
  3. Atrial tachycardia (rhythm disturbance that arises in the atria)
  4. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Bladder outlet obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded)
  7. Blepharitis (chronic inflammation of the eyelid)
  8. Blood pressure decreased
  9. Breath sounds
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. Pain: 16 people, 64.00%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Celestone and Soma?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Celestone and Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Celestone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Soma:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celestone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Soma and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on betamethasone and carisoprodol (the active ingredients of Celestone and Soma, respectively), and Celestone and Soma (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: